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1. Introduction
1.1 Objective of thesis
Zymogen granules (ZGs) are lysosomes, digestive vesicles, which are important in
the digestive process of proteins, fats and carbohydrates. The surface of the cell membrane
of these granules is covered with various molecular motor proteins.1 Among them are
several species of myosin; myosin 1c, myosin 5c, myosin 6 and myosin 7b. Other important
signaling and transport proteins include dynein, rab27b, vamp2 and syntaxin 7 and 12.
The presence of these various myosins would necessitate the transportation along
actin filaments while tethering cargo during exocytosis. In order to investigate the
movement of ZGs, the use of a single beam optical trap that has become ubiquitous in
biophysics research is used. The ability of infrared optical traps to measure nanometerscale steps and piconewton scale forces has been invaluable since their development.2 The
usefulness of optical traps has been increasing rapidly in their development and the
relatively low amounts of protein and cellular damage caused by low power infrared traps
make them amazing tools for conducting in vivo trapping experiments.
Our experiments utilizing the infrared optical trap allows us to safely trap freshly
purified ZGs and manipulate them over actin filaments. We can then identify stepping,
determine information about the myosins involved, and attempt to characterize the
complicated process of ZG transport.

1.2 Specific aims
Our first objective in this thesis is to provide some biological background. The
functioning of the pancreas and production of ZGs is explored and along with the roles and
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importance of cytoskeletal motors. In particular myosins are introduced as the various roles
and functions they play are essential for the proper functioning of a variety of cells and
systems. Further details are given for four myosins; myosin 5, myosin 6, myosin 1 and
myosin 7. These particular isoforms are relevant to our ZG studies as they have been found
on the ZG membrane. A brief introduction to basic total internal reflection fluorescence
(TIRF) microscopy and optical trapping follows as a backdrop for the main experimental
techniques that follow.
Secondly, a discussion of various methods and experimental protocols will provide
further background and details including various protein and reagent preparations,
purifications, and labelling procedures. Next a more thorough explanation of our
microscope and optical trap setup are given. The various methods for calibrating and
preparing the trap along with the basic chamber preparation for trapping and data collection
is discussed
The third aim will be to demonstrate the ability of our setup to trap ZGs. By
verifying the attachment of ZGs to actin filaments while inside the trap we will then show
the stepping behavior observed in the presence of ATP. The effects of varying ATP
concentration and ionic strength has been observed along with the effects observed using
a myosin 6 inhibitor.

1.3 The pancreas
The pancreas produces liters of fluid a day containing the enzymes needed to
breakdown and digest most all the organic compounds ingested. An important organ of
the exocrine system, the pancreas produces trypsin and chymotrypsin, among other
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enzymes, to digest proteins, amylase to digest carbohydrate, and lipase to digest fats.3 The
highly active pancreas produces these enzymes in specialized cells called acinar cells.
There are many physiological stresses on these acinar cells that are associated with high
levels of protein synthesis and the production and storage of potentially dangerous
digestive enzymes. These stresses that include high levels of intracellular trypsin build-up
can lead to acinar cell destruction and several pathologies. In a properly functioning
exocrine system, these enzymes are stored in precursor forms and are not activated until
they reach the duodenum.3
The storage unit inside these acinar cells for these enzymes are vesicles called
zymogen granules (ZGs). These ZGs must traffic and function properly to avoid being
harmful to themselves or other cells. If something goes wrong and these enzymes are
activated elsewhere there can be disastrous effects. For example, trypsin is able to activate
the pro-inflammatory NF-κB signaling pathway. This deregulated inflammation, improper
activation, and over accumulation of these digestive enzymes can lead to tissue damage
and acute inflammatory diseases like pancreatitis.4

1.4 Zymogen granules and vesicle transportation
Vesicles and vesicle transport are vital to the performance and proper functioning
of all cellular organisms. Vesicles are formed by lipid bilayers that are capable of
maintaining an environment that segregates the inter- and intra-vesicle environment.
Maintaining cellular organization, transporting cargo, metabolizing material, and other
important functions are carried out by various vesicles. These roles are essential to life and
the proper functioning of all organisms. For example, the malfunctioning of vesicles has
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been linked to several diseases including Alzheimer’s, 5 diabetes, 6 epilepsy7 and various
forms of cancer8 involve a disorganization of vesicle formations and transportation. The
wide variety of processes affected by vesicles and their impact on a variety of diseases
illustrates their diverse roles and importance.
There are several types of vesicles: vacuoles, lysosomes, transport vesicles,
secretory vesicles, extracellular vesicles, and others, including gas vesicles which aid in
maintaining buoyancy for some microorganisms.9 Vacuoles are used by plant cells to store
nutrients and to maintain the proper osmotic pressure to keep the cells from lysing.10
Lysosomes contain digestive enzymes that are used to break down food during digestion.11
Transport vesicles move cargo between areas of the cell, from the endoplasmic reticulum
to the Golgi apparatus for example, and perform other duties necessary for functioning.
The majority of vesicle traffic is carried out by the molecular motors kinesin and
dynein utilizing microtubules as tracks or myosin utilizing actin filaments as tracks. The
cytoskeletal tracks allow for the motors to bind and move along in a directed fashion while
carrying the vesicles as cargo. In addition to vesicle transport varying for particular
vesicles, vesicle size also ranges widely from synaptic vesicles that are 40 nanometers in
diameter12 to extremely large apoptotic bodies that could be 5-10 microns in diameter.13
One particular example of a vesicle is the ZG (Figure 1.1). ZGs are specialized storage
organelles in the exocrine pancreas that allow the sorting, packaging, and regulated apical
secretion of digestive enzymes.14 ZGs have been shown to contain several species of
myosin in their cellular membrane,1 and their size of approximately one micron in diameter
makes them great candidates for study using optical tweezers. During the trafficking of
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ZGs, and any other vesicles using actin or microtubule binding molecular motors, the motor
proteins generate pico-newton forces and propel the vesicle in nanometer sized steps along
the filament track. In order to measure these forces and step sizes optical tweezers are
uniquely suited for the task.

Figure 1.1 Molecular topography of pancreatic zymogen granule protein. Cartoon of
various membrane and transmembrane proteins found on zymogen granules. Figure from
Chen (2008).15

1.5 Cytoskeletal motors
Molecular motors consist of two major types. One generates linear movement while
the other creates rotational movement. The former has two different tracks they move
along; actin filaments and microtubules. One can further classify these motors into four
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major groups; myosin, kinesin, dynein, and rotational motors, e.g. F1F0. Myosin is an actin
binding motor, while kinesin and dynein are microtubule motors. The myosin motors are
classified based on their amino acid sequence homology and all different isoforms of
myosin are called the myosin superfamily tree (Figure 1.2).16

Figure 1.2 Myosin superfamily tree The 35 classes of myosin found in eukaryotes. Figure
from Oronditz and Kollmar (2007).
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Myosins are classified currently into 35 classes in all eukaryotic cells.17 Myosins
are motor proteins that bind ATP (Adenosine triphosphate) and hydrolyze it to ADP
(adenosine diphosphate) and Phosphate (Pi). The hydrolyzed energy may be used for force
generation. They are involved in a wide variety of cellular functions including muscle
contraction, maintaining the morphology of organs, and the transportation of cargo.
The one common function of molecular motor myosins is their ATPase cycles.
Molecular motors exchange the energy from ATP hydrolysis to mechanical force. The
ATPase cycle has many steps (Figure 1.3), including the conformational change of myosin.
When myosin binds to ATP, the affinity of the motor domain of myosin to actin decreases
and dissociates from actin. This step is called the weakly-binding state. Then, the motor
domain hydrolyzes ATP to ADP and phosphate (Pi) and changes the conformation. The
affinity between myosin and actin increases. This is called the strongly-binding state. The
motor domain binds to actin and releases Pi. Then, the motor domain changes the
conformation, termed a power stroke. After the power stroke, the motor domain releases
ADP. In the Figure 1.3 A, one motor domain is shown instead of two motor domains to
make the illustration simpler. Figure 1.3 B. shows the ATPase pathway with weaklybinding and strongly-binding states. The Green is the common pathway of the ATPase
cycle.
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Figure 1.3 ATPase cycle. (A) ATPase cycle of single-headed motor. ATP as an orange
star, ADP as blue star, Pi as green hexagon. “-“means binding. (B) ATPase scheme of
myosin only (bottom) and actomyosin (top).
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In general, myosin’s structure consists of three parts; motor domain, neck region,
and tail region (Figure 1.4). The motor domain has an ATP binding site and an actin binding
site. The neck region binds a small protein called calmodulin and calmodulin-like proteins
that are about 18 ~ 26 kDa in size. These light chains and/or calmodulin stabilize the αhelix structure working as a lever arm. However, a single α-helix (SAH) structure was
found that also works as a lever arm without calmodulin for myosin.18 The tail region of
myosin has a wide variety of structure. For example, class 2 myosin has a tail region that
forms a coiled-coil to make a dimer of two myosin monomers, termed the heavy chain, and
forms myosin filament with about 50~100 myosin molecules. Other domains, named
FERM, SH3, MyTH4, PH, ankyrin repeats, and globular tail domains have their own
functions in protein-protein binding.

Figure 1.4 Myosin Molecule. Illustration of a myosin molecule. All myosins contain a
motor head with an ATP binding region. The lever arm, dimerization domain and cargo
binding domain are variable between myosin classes. Note: the reverse gear after the motor
domain in unique to myosin 6. Figure from Sweeney and Houdusse (2010).
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There are single- or two-headed myosins. To form two-headed dimers, the tail
region has a coiled-coil amino acid sequence. For example, myosin 1, 3, 9, and 14 are
single headed myosins, while myosin 2, 5, 7, and 10 are two-headed myosins.

Figure 1.5 Single and double headed myosin. Portion of the myosin family tree showing
common single and double headed myosin species. Figure adapted from Hodge and Cope
(2000).19

One of the important features of molecular motors is processivity. This means that
a single motor protein continuously moves along tracks and takes multiple steps without
dissociation from the tracks. On the other hand, non-processive means that the motor
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molecule dissociates from the track without movement (steps). In order to understand the
processivity, the duty-ratio is an important factor which is the fraction of an ATPase cycle
the motor remains bound to actin. The difference between a processive and non-processive
motor is the duty-ratio that is the fraction of myosin-actin binding time in the ATPase cycle.
A high-duty ratio (e.g. > 50%) suggests that the motor is processive, on the other hand, a
low duty-ratio (e.g. < 50%) suggests that the motor is non-processive. This means that twoheaded motors bind on an actin filament and the trailing head of the molecule is detached
from the actin by the power stroke of the leading head that is still tethering the myosin to
the actin filament. Before the leading head dissociates, the trailing head swings forward to
a new binding site on the acting filament.
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Figure 1.6 Hand-over-hand motion of myosin 5. Schematic showing the stages of the
myosin stepping process.

Recent studies suggested that myosin 5 may be involved in vesicle transportation
and has been found localized in melanosomes and synaptic vesicles.20, 21 It has also been
shown to act like a tether, anchoring organelles and vesicles in place in vast actin networks
within the cell. Mutations that result in defects of human myosin 5a genes have been shown
to cause Griscelli disease22, a fatal disease which causes the onset of uncontrolled
macrophage activation and is fatal if not treated with a bone marrow transplant.
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It has long been thought that microtubules direct long range transport, while myosin
moving along actin filaments mediates short range transport.23 Studies have shown that a
new model where transport is divided into centrifugal (actin dependent) and centripetal
(microtubule dependent) relies on myosin 5a transporting cargo predominantly
centrifugally around the cell and that transport along actin tracks can indeed be long
range.24

This method of transport along vast networks allows vesicles to move

directionally globally yet randomly locally.25 Myosin 5a has also has been shown to
mobilize GLUT4 vesicles in muscle cells.23, 26 Several myosins, including 5a, non-muscle
myosin 2, and several other non-conventional myosins are being found to have a profound
role in the exocytosis of secretory vesicles.20
The myosin superfamily is very diverse and ubiquitous to all animal cells. There
various structures and amino acid sequences allow them the ability to perform a myriad of
tasks for the proper function of the organism. In particular, their role in vesicle transport is
important for many cellular functions from endo- and exocytosis to neurotransmitter
secretion. Many important functions of vesicles themselves are an important area of
research to help develop novel treatments for many diseases. The mutation of a number of
these myosins can lead to disastrous effects and their study also may lead to the treatment
or characterization of many diseases as well. The recent discoveries of the link between
myosin and vesicle transport should be an interesting area in the future as these two very
diverse and important aspects of physiology come together to perform many amazing
functions that are yet to be fully understood.
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1.6 Myosin 5
Myosin 5 is a plus-end directed two-headed high duty-ratio motor that has been the
most studied myosin in two decades.27, 28 Class 5 myosin in mammalian cells has three
isoforms, myosin 5a, myosin 5b, and myosin 5c. These myosins are used as vesicle
transporters in cells. Myosin 5a and 5b are processive motors, meaning that a single
molecule continuously moves along an actin filament without dissociation, while myosin
5c is a non-processive motor.
A factor that increases the duty ratio and therefore the processivity of some
isoforms of myosin 5 is that when both heads are bound to actin, the front head dissociation
kinetics decrease 50-fold, thereby increasing the chances of the trail head detaching while
the front head remains bound.29
Myosin 5a is known to be involved in the trafficking of melanosomes, which are
responsible for pigmentation.30 Mutations in the gene encoding for myosin 5a leads to
Griscelli syndrome, a hypopigmentation that results in pale skin and ashen hair.31 Myosin
5a is also found in the brain and mutations in the myosin 5a gene have been shown to have
disastrous neurological effects ranging from mild cognitive and motor impairment to fatal
neurodegeneration.32
Myosin 5b has plays a role in several physiological processes including
postsynaptic plasticity33, 34 and epithelial polarization.34, 35 Mutations in the gene encoding
for myosin 5b has been linked to microvillus inclusion disease36, which is a disease of the
intestinal tract. Specialized cells of the intestinal lining lack microvilli in people with
microvillus inclusion disease and severe cases can be life threatening.
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Myosin 5c, being very similar in structure and function to other class 5 myosins,
are also essential is membrane organelle and vesicle transport. While myosin 5c is a low
duty ratio non-processive motor, when two myosin 5c molecules are coupled together, they
have been shown to become processive.37 This ability to develop processive movement
with multiple myosin 5c motors may be crucial for it to fulfill its various cargo transport
roles that it is thought to be involved in.

1.7 Myosin 6
Myosin 6 is a unique member of the myosin family as its movement is directed
toward the minus-end of actin filaments, meaning that it walks backwards compared to the
majority of other myosins.38 Myosin 6 is predominately a monomer, however studies have
shown that artificial dimeric myosin 6 can be processive with large step sizes around 30
nm.39 Newer studies have theorized that while the myosin 6 found in cells are
predominately monomers, there are cargo induced mechanisms that induce dimerization.40
The motor activity of myosin 6 seems to be regulated by cargo and proteins called dimeric
adapter proteins. One such protein, optineurin, targets myosin 6 near the Golgi apparatus
where it enables the dimerization of myosin 6 to help stabilize the Golgi.41 There are other
mechanisms for the dimerization of monomer myosin besides the use of these adapter
proteins. It has been shown that myosin 6 clustered at high densities can lead to
dimerization as well.42 Even monomeric myosin 6 is capable of generating large steps, 1830 nm, and has been shown in vitro to be capable of processive movement,43 though this
monomeric locomotion may not be possible in vivo under the forces and stresses
encountered. This ability of myosin 6 to move in either dimeric or monomer form would
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allow it to aid in tethering or moving cargo even when there are no adapter proteins present
or if the cargo itself has a very low concentration of myosin 6 where no cluster density
dimerization would take place.
If myosin 6 and other similar myosins cannot function as monomers then models
for dimerization become necessary. One such model posits that myosin 6 is a nonfunctional monomer in a folded state unless bound to cargo.44 When two such monomers
are in close enough proximity, the folded regions that prevent dimerization normally are
exposed. This unfolding is aided by cargo binding and allows the dimerization to take place.
One possible reason for the existence of these non-functional monomers that only become
active when bound to cargo may be that the monomers can diffuse through the cortical
actin network easier in this state.40 These dimers are critical in anchoring cargo, not only
in processive movement. The dimerized myosins gated heads, their ability to coordinate
themselves, are essential in these anchoring scenarios, not only in processive movement.
Myosin 6 dimers that have defective gating are not able to stabilize stereocilia in mouse
hairs and leads to deafness.45
Whether it be processive movement of cargo or cargo anchoring, myosin 6 plays
several roles in many cell processes including endocytosis, Golgi function, cell adhesion,
cytokinesis, stereocilia stabilization, and many others.40

1.8 Myosin 1
Myosin 1 proteins were first discovered46 in 1973 and exist in several isoforms.
Myosin 1 has been shown to be involved in endocytosis, exocytosis, intracellular
trafficking and nuclear organization.47 During exocytosis, when vesicles fuse to the plasma
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membrane, the process is aided by actin coats. Actin coats are actin layers of secretory
vesicles that aid in the stabilization during fusion and contract during the post-fusion
process to precipitate the exocytosis process.48 There are species of myosin 1 that either
aid in the contracting or relaxing of these actin coats which is one method for fine tuning
the exocytosis process.49
Myosin 1 has some responsibility in regulating the cortical tension through
attachments between the cell membrane and the cortical cytoskeleton.50 Other isoforms of
myosin 1 may contribute to actin filament architecture in various ways, possibly by aiding
in G-actin transport.47 In addition to the actin tethering to maintain the tension and structure
of cells, this tethering role may also be a key factor in various forms of molecular transport.
For example, in kidney cells Myosin 1b has been found in renal proximal tubule cells and
is thought to anchor amino acid transporters in the cellular membrane.51 A similar
transmembrane tethering function has also been proposed for myosin 1a. A large
transmembrane disaccharidase, sucrose isomaltase, found in the intestinal brush border
membrane, is hypothesized to be localized or otherwise be retained in part by myosin 1a.52
A unique characteristic of myosin 1b is its tension sensitivity. Typically, after binding to
actin and undergoing its powerstroke, myosin 1b detaches from actin in ~1s. However,
under resistive loads of 1-2 pN, myosin 1b remains attached to actin for upwards of 80100s.53 This unique sensitive allows for myosin 1b to be utilized in several roles from
tethering and transport to acting as a force sensor.
Like many other myosins, another critical role of myosin 1 is in intracellular
transport. An important component of cellular trafficking is docking and tethering. It has
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been shown that myosin 1c can stop vesicle trafficking along microtubules at actin
intersections.47 This interestingly connects microtubule and actin based transport, the two
main methods of intracellular trafficking.

1.9 Myosin 7
Myosin 7 is a plus-end directed single-headed molecular motor. There are two
isoforms of myosin 7: myosin 7a and myosin 7b, with myosin 7a having been shown to be
involved in lysosome transport.54 Myosin 7 is a very slow motor with dwell times greater
than three seconds and appears to play critical roles in hearing and vision loss.55 It is
thought that myosin 7a maintains the arrangement of stereocilia and crosslinks adjacent
stereocilia which is essential to the proper functioning of the auditory system.56
Usher syndrome is a disease that is the cause of genetic deaf-blindness that leads to
retinitis pigmentosa sensorineural hearing loss.57 The gene encoding for myosin 7a was
one of the first genes to be found associated with Usher syndrome.58 There is a network of
several proteins found mainly in the stereocilia of hair cells in the ear in photoreceptor cells
called the USH interactome.57 Many of these proteins are linked together or to the
cytoskeleton by tethering proteins like myosin 7a.57
There has been other roles discovered for myosin 7a in the vision process that can
also lead to retinal degeneration and other visual health problems. In addition to its
tethering ability, myosin 7a has been shown to be responsible for organelle transport in the
retinal pigment epithelium.59 Deficiencies in myosin 7a leads to retinal degeneration in
Usher 1B patients from an accumulation of cellular defects caused by disrupting the visual
cycle.59
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1.10 Processivity and Duty ratio
Two terms mentioned in the discussion of different myosin species, processivity
and duty ratio, dramatically impact the ability of myosin to be effective in their cargo
transport function. Actin filaments are the tracks that myosin move along and they
polymerized in one direction. The direction of polymerization is termed the plus end while
the other end is the minus end. During myosin movement along actin, it does so typically
toward the plus end, though there are certain myosins that do not, myosin 6 for example
(Figure 1.7).

Figure 1.7 The directionality of actin filaments. Illustration of the plus and minus ended
actin with myosin 5 and myosin 6 examples of movement direction. The 36 nm helical
repeats of the actin filament is shown in blue. Figure adapted from Kinoshita et al. (2005)60

The term processivity refers to the ability of a motor to bind to actin and take several
steps along the filament before dissociating. The duty ratio of a molecular motor is
intimately related to its processivity. The duty ratio is simple the fraction of the ATPase
cycle that the motor remains bound to actin. So a very low duty ratio motor would spend
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the majority of its ATPase cycle dissociated from the actin filament. Clearly then, the
higher the duty ratio of a motor, the more likely it is to be processive.

1.11 Single Molecule Techniques
1.11.1 Total Internal Reflection Fluorescence Microscopy
In order to conduct optical trapping experiments using ZGs bound to actin filaments,
fluorescence techniques are required to verify and locate the position of fluorescence
labelled actin filaments. One way of achieving this is using total internal reflection
fluorescence microscopy (TIRFM) and rhodamine phalloidin (RhPh) labelled actin
filaments.
The technique of TIRFM has been widely used for decades.61 It is a simple yet
powerful tool that be used to stimulate fluorophores near the very surface of a coverslip.
Using the proper wavelength laser for the appropriate fluorophore, the laser is directed
through the microscope objective. Visualizing the coverslip with the laser shining straight
through would result in a wash out as all the fluorophores are excited throughout the sample.
To avoid this and to excite only a thin region near the surface, the angle of the laser incident
on the coverslip is changed until the critical angle is reached and the laser is total internally
reflected. Once this happens only the exponentially decaying evanescent wave propagates
into the sample, thus only exciting the fluorophores roughly 100 ~ 300 nm deep into the
sample. Using this method, the surface of an actin-bound coverslip can be visualized
crisply without exciting all of the actin inside.
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1.11.2 Optical trapping
Mechanical forces play an important role in biological processes.

From

intercellular transport, cell motility, and cell adhesion, the generation of these forces is
critical for many cellular functions. To generate these forces, molecular motors convert
chemical energy into mechanical energy. One of the most widely used techniques to probe
these forces is the single beam optical gradient trap (optical tweezers).62 Optical tweezers
allow for the detection of extremely small forces on the pico-newton scale and gives the
investigator the ability to completely release the trapped particle, something unique to this
technique. This ability to control the release of trapped particles has been used in studies
where the specific delivery of controlled particles, parasites for example, was used to
examine cell invasion events.63
The basic theory of optical tweezers can be explained by momentum transfer.
When the laser hits a dielectric surface, it carries with it momentum. The reflection and
refraction of the light changes its momentum at this surface and from momentum
conservation the dielectric will have an equal and opposite momentum change. Where there
is a change in momentum, there is a force (Figure 1.6).
If the force due to the refracted rays is larger than that of the reflected rays, the
force will push the dielectric toward the center and this restoring force will stabilize the
trap (Figure 1.6). This net force of refraction increases with increasing angle while the
force from reflection decreases with increasing angle. This leads to the restoring force
being stronger for increasing angle and requires a minimum angle for stable trapping.
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Figure 1.8 Basic principle of optical trapping.
Ray tracing diagram depicting momentum change
when a ray is incident on a dielectric sphere. (A) A
single photon (red arrow) changes momentum (P1
and P2) when the refractive index changes. The
resulting momentum change is ∆P. (B) A laser
passes through a bead and the photon momentum
change produces a momentum change for the bead.
Green arrow represents the force on the bead.
Below is the Gaussian distribution of the laser
power.
It is also possible to explain the trapping force using the Lorentz force. The laser
induces a dipole moment in the dielectric. This induced dipole moment is proportional to
the electric field. The total energy of the induced dipole in the field is then

= − ∙

∝ − ⋅

∝ −

The intensity, I, is proportional to the square of the electric field in an isotropic
medium with a polarizability that is linear in

and the force is thus proportional to ∇I.

Thus, the energy of the particle is at a minimum where the intensity is maximum, in the
center of the laser beam.
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In the Rayleigh regime (d << λ), the trapped particle acts as a dipole in the electric
field of the laser. The gradient force acting on a dipole can be calculated in this limit.

For a linear polarization,
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This tells us that the gradient force is proportional to the intensity gradient. For a
Gaussian beam this would be toward the beam axis and for a beam focused through an
objective as in an optical trap, it would be toward the laser focus.
Of course there is also a force due to the radiation pressure from the laser. This
additional force, called the scattering force, acts in a way to push the particle downstream
of the laser propagation. So long as this scattering force is overcome by the gradient force
you will produce a stable trap.
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1.11.2.1 Brownian motion in a harmonic potential
Small displacements from the center of an optical trap may be approximated as a
harmonic potential. The Brownian motion for such a particle is described by the Langevin
equation,

where

*+, + -+. + /+ =
is the fluctuating Brownian force. In the low Reynold’s number regime, we

can ignore the inertial term and the viscous term dominates.
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Taking the Fourier transform of the equation of motion,
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Considering only positive frequencies and using the one-sided Lorentzian, the power
spectrum is thus:
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This is a Lorentzian with corner frequency k/2πγ.

2 Methods
2.1 Protein and reagent preparation
2.1.1 Buffer recipes
1x Motility buffer (MB) was diluted four times from 4x MB. 4x MB consists of 80
mM MOPS pH 7.0, 20 mM MgCl2, 0.4 mM EGTA, and 0.1 mM NaN3. The necessary
concentration of potassium chloride (KCl) is added to MB that that is prepared from 3M
KCl stock solution.

2.1.2 Biotin labeled BSA
1 ml of 6.7 mg of BSA is dissolved in 1 ml of 0.1M boric acid, pH 8.8. 2.8 mg of
biotin (EZ-link™-NHS-LC-LC-biotin, Thermo Scientific, Cat# 21343) is dissolved in 50
µl of DMSO and mixed with the BSA. The mixture is then put in dialysis with 200 ml of
the following buffer: 50 mM KCl, 5 mM Tris, 0.1 mM NaN3 and the pH adjusted to 8.0.
The dialysis buffer used here is changed up to 5 times over the next several days. The
biotinylated BSA is aliquoted in Eppendorf tubes, flash frozen in liquid nitrogen, and stored
in a -20 ̊C refrigerator for future use.

2.1.3 Actin preparation
Actin was prepared from rabbit skeletal muscle and purified as described in
Spudich J.A., Watt S., J. Biol. Chem. 26, 1971. The details are shown below.
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2.1.3.1 Acetone powder
Acetone powder was prepared from rabbit muscle that was purchased frozen. The
frozen rabbit muscle (500g) is broken down into small pieces and minced twice. GubaStraub buffer consisting of 0.3 M KCl, 0.1 M KH2PO4 pH 6.4, 5 mM MgCl2, 1 mM ATP,
and 1 mM DTT is added to a volume of three times the rabbit muscle and stirred for 15
min at 4 °C. The muscle solution is centrifuged at 6500 rpm for 10 min (Beckman J2-MI,
JA-20 rotor). The pellet has actin, while the supernatant has myosin. 1.5 L of cold ddH2O
is added to the pellet and resuspended. The resuspended solution was filtered by gauze that
is autoclaved beforehand. Adding cold ddH2O lowers the ionic strength of the muscle
mixture. After filtering, cold ddH2O with 0.1% NaHCO3 is added to the muscle and stirred
for one hour at 4 °C. Then, the muscle solution was filtered again through gauze. Again,
the muscle pellet was resuspended in cold ddH2O with 0.1 % NaHCO3, stirred for one hour
at 4 °C and filtered by a gauze. The muscle pellet was again resuspended with room
temperature ddH2O with 0.1% NaHCO3 and stirred for two hours at room temperature.
After two hours, the muscle solution was filtered through gauze. To remove 0.1% NaHCO3,
muscle pellets were resuspended and filtered twice with room temperature ddH2O. The
pelleted muscle was resuspended in cold acetone (1.5 L), stirred 1 min at 4° C, and filtered
by a gauze. Cold acetone is added again to the muscle pellet and resuspended and stirred
for 3 min at 4 °C and filtered. Room temperature acetone is then used to resuspend the
muscle pellet and stirred for 30 min. Room temperature acetone is used again to resuspend
the muscle pellet and stirred for 2 hours and filtered. The pellet placed is placed on filter
paper to dry overnight. The acetone powder can be stored at -80 °C.
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2.1.3.2 Actin preparation from the acetone powder
Before the preparation, G-buffer is prepared with 2 mM Tris base, 0.2 mM CaCl2,
0.2 mM Na2ATP, 1 mM NaN3, and 0.5 mM DTT. Before adding ATP and NaN3, the pH
was adjusted to pH 8.0 at room temperature with HCl or pH 8.6 at 4 °C. G-buffer will be
used for actin de-polymerization. Salt concentrations above a certain threshold will prevent
the actin from de-polymerization. If the pH is not properly adjusted and the solution is
back-titrated with NaOH, there will be a higher risk of having the final ionic strength too
high preventing the actin from depolymerizing.
Frozen acetone powder (5g) is suspended in 100ml G-buffer. The yield of this
preparation should be around 100 mg actin. By using a magnetic stir bar, the acetone
powder is slowly stirred on ice without frothing for 30 min. The stirred acetone powder is
filtered through two layers of paper filter (Whatman #1) under an air vacuum. The acetone
powder on the filter paper is taken back to a beaker and suspended in 50 ml G-buffer to
extract more actin protein and stirred 20 min on ice and filtered the same as above. The
first and second filtered solution are combined and are centrifuged one hour at 10500 rpm
with a Beckman centrifuge using a JA14 rotor. After the centrifugation, the supernatant is
taken into a graduate cylinder and the volume measured. 3M KCl, ATP, and 3M MgCl2
are slowly adding into the supernatant to reach the final concentration as 50 mM KCl, 1
mM ATP, and 2 mM MgCl2. Note that we do not need to take into account the
concentration of these reagents in the G-buffer. The actin solution is placed on ice and
incubated for two hours. G-actin slowly polymerizes to F-actin. The solution should
increase in viscosity. If this doesn’t happen, then you did not get a good extraction of actin.
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After two hours, grounded KCl powder is adding to the actin solution to reach the final
KCl concentration of 0.6 M. The solution is slowly mixed until the KCl powder dissolves
completely. The solution is centrifuged in an ultra-centrifuge (Beckman Optima MAXXP, TLA 110 rotor) at 100,000 rpm for 45 min at 4 °C. After the centrifugation, the
supernatant is discarded, and the pellets are soaked for one hour in 1 ml G-buffer. This
makes the pellets softer. Note that the amount of G-buffer will determine the final
concentration of F-actin, so it is advised to not add too much G-buffer. Using a wide-tip
transfer pipet, made by cutting the tip of a 1 ml pipet tip slant-ways, take the soaking
solution and resuspend the pellets. The resuspended pellet is transferred to a dialysis bag
(Cellulose Ester, 10 mm wide, MWCO: 100 – 500 Da, Spectra/Por Biotech) and dialyzed
with 1 L G-buffer in 4 °C overnight. Every 24 hours, the G-buffer (1 L) is changed twice.
After three dialysis three times, the actin solution in the dialysis bag is transferred into a
homogenization tube and homogenized. The homogenized actin solution is transferred to
a centrifuge tube and centrifuged with an ultra-centrifuge at 100,000 rpm for 45 min at 4
°C. Then the supernatant is transferred to 15 ml plastic tube. G-actin concentration is
determined by a spectrophotometer (Varian Cary 50 Bio UV-Vis Spectrophotometer). The
G-actin solution is diluted 10 and 100 times and measured at 280 and 320 nm wavelength.
The molecular coefficient and molecular weight of G-actin is 0.63 and 42,000 g/mol. Note
that OD 320 nm provides a correction for scattering. To calculate G-actin concentration,
the following equations are used:
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G-actin is usually 100 ~ 150 µM (4.2 ~ 6.3 mg/ml). G-actin can be stored as 10 µl
frozen balls in liquid nitrogen indefinitely.

2.1.3.3 Biotin-labeled G-actin
G-actin (10 µM) was mixed with 50 µM Biotin (Ez-link Sulfo-NHS-SS-Biotin,
Pierce, Cat#: 21331) in a solution containing 20 mM TES-HCl (pH 7.0). 0.1 mM NaN3,
0.2 mM ATP and incubated for one hour at R.T. 5 mM DTT is added into the Biotin-Gactin solution to stop the reaction. The biotin-G-actin is dialyzed with G-buffer. After the
dialyzed, G-actin concentration was measured and stored as a frozen ball in a liquid
nitrogen. Biotin-G-actin and G-actin are mixed with 1: 9 ratio and polymerized as adding
3M KCl and 1 M MgCl2 for final concentration 50 mM and 2 mM, respectively.

2.1.3.4 Rhodamine labeled biotin F-actin
10% Biotin-labeled actin filaments were fluorescently labelled by RhodaminePhalloidin, RhPh, (300 unit, Cat#: R415, Thermo Fisher). Actin and RhPh are mixed in a
one-to-one ratio. 100 µl of 2 µM Biotin-F-actin and 33.3 µl of 6 µM RhPh used. First, 6µM
RhPh is taken in an Eppendorf tube and is evaporated in ethanol for 15 min by a vacuum.
After all ethanol is dried, 3 µl ethanol is used to suspend the dried RhPh. F-actin (2µM,
100µl) is added to it and incubated for 15 min on ice to bind together.
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2.1.4 SDS-PAGE and Western blot
The protein extracted from Sf9 cells or rat pancreas were separated by sodium
dodecyl (lauryl) sulfate-polyacrylamide gel electrophoresis, SDS-PAGE, followed by two
rounds of staining. First, to visualize protein, Coomassie Blue R250 (Thermo Fisher, Cat#:
20278). The solution of Coomassie Blue R-250 (CBB-R250) is prepared from 50 mg CBBR250 dissolved in 50 ml Methanol followed by adding 100 mM 85% H3PO4. 500 ml ddH2O
is added into the solution and mixed well. The solution is then filtered with a vacuum and
350 ml H2O is added. This CBB-R250 solution is stored at 4 °C. Zymogen granule sample
was boiled with protein sample buffer (see above) and 12 µl added into each well of 4-20%
polyacrylamide/bisacrylamide (40:1) gel. The sample runs at 100V and 0.2A for 30~45
min. The gel is immersed into fixation buffer (40% Methanol, 10% acetic acid solution)
for 15 min and rinsed with ddH2O three times for 5 min each. The gel is immersed 30 ~ 60
min into a staining solution (2.5 g CBB-R250, 500 ml Methanol, 50 ml Acetic Acid, and
450 ml ddH2O). A de-staining solution (50 ml Methanol, 70 ml Acetic Acid, & 880 ml
ddH2O) is added onto the gel and shook with a rotary shaker (90 rpm) for 60 min. The destaining solution is changed twice every 60 min. Finally, the gel is rinsed three times with
ddH2O. Protein bands will shop up along with protein maker that was loaded into the gel.
The gel is visualized by an imaging system (Bio-Rad, Gel Doc EZ imager). Note that if a
stain-free gel is used for the SDS-PAGE, we don’t need to stain CBB-R250 and can
immediately image the gel.
A western-blotting staining technique is utilized to confirm target proteins.
Western-blotting is widely used biological, biochemical, and medical research laboratories.
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Briefly, purified myosin 5a-HMM from Sf9 cells or zymogen granules from rat pancreas
are mixed with 5x SDS-sample buffer in a 4:1 volume ratio, and run on 4-20% gel with
acrylamide: bisacrylamide ratio of 40:1 (TGX Stain-free 4-20%, Bio-Rad, Cat #456-8095).
Note that protein standard (BIO-RAD, cat#: 161-0364 for no-color, 161-0324 for
kaleidoscope pre-stained standards) will run at the end of gel. The protein bands resolved
were directly imaged using TGX Stain-free gel. Proteins in the gel were then transferred to
nitrocellulose membrane (Invitrogen PVDF, Invitrogen, Cat# LC2005) by Trans-Blot
Turbo System at 25V, 1.0A, for 30 min ~ one hour. The transferred membrane is visually
checked after the transfer to see the amount of transferred proteins. If there is not enough
transferred protein, transfer voltage or time will be increased the next time. The membrane
is immersed into 5% skim milk in 0.05% Tween® 20 TBS for 30 min to block the
membrane. A first antibody (10 µl) is directly added into the membrane with milk solution
used in blocking. Note that the dilution factor of antibodies varies, but usually it is 1,000
to 3,000. If the membrane incubates with the first antibody overnight, the membrane will
be stored at 4 °C while rocking. If you complete the western-blot the same day, the first
antibody with milk solution is taken into a 15 ml tube and saved for save next western blot.
TBS with 0.05% Tween® 20 rinsing solution is added to the membrane to rinse the first
antibody three times for 5 min each. A second antibody is prepared to a certain dilution
factor with the same skim milk and TBS with Tween® 20 mixture as above. The second
antibody is added onto the membrane and incubated for an hour at room temperature. The
membraned is washed three times again with the TBS rinsing solution mentioned above,
each time shaking for 5 min for each wash step. Lastly, a developing solution (Western-
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Blot® Stabilized Substrate for Alkaline Phosphatase, Promega, Cat#: S3841) is added onto
the membrane to visualize any antibody binding.
To examine existing myosins on the ZG’s surface, we have used enhanced
chemiluminescence (ECL) WB. The advantage of the ECL WB substrate is a higher
sensitivity and without using radioactive methods. Using a luminol-blotting substrate, the
ECL can detect horseradish peroxidase (HRP) as a secondary Ab on immunoblots. The
sensitivity of ECL can detect picogram levels of protein using a fluorescence imaging
system. The reaction in figure 2.1 emits in the 428 nm range to image the bands.

Figure 2.1 Enhanced chemiluminescence reaction. Schematic of the fluorescent reaction
in ECL imaging.

2.1.5 Myosin 5c construct and preparation
The plasmid containing the cDNA sequence of full length human Myo5c was
provided by Dr. Cheney, University of North Carolina at Chapel Hill. The cDNAs
encoding Myo5c sub-fragment 1 (Myo5c-S1, 1–785 amino acids) and heavy meromyosin
fragment (Myo5c-HMM, 1–1109 amino acids) were amplified by PCR and sub-cloned into
pFastBac1 vector (Invitrogen). The Flag epitopes (DYKDDDDK) were engineered into the
vectors before the stop codon. To generate Myo5c-HMM with a SNAP-tag, which is used
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for linking Myo5c-HMM fragments to a polystyrene spherical bead as a scaffold, the
cDNA encoding SNAP (snap26b, New England Biolabs) was inserted immediately after
Myo5c-HMM followed by either a FLAG tag or six repeated histidines (6x-His) before the
stop codon. All the constructs were verified by DNA sequencing. Myo5c-S1 and -HMM
proteins were expressed using the baculovirus Sf9 system and purified by anti-FLAG
affinity chromatography as described previously.64
Proteins of Myosin 5c-HMM and Myosin 5c-HMM-SNAP was expressed in a
baculovirus expression system. The cDNA plasmid of both myosin are transfected into
DH10Bac E. Coli Cells. A recombinant bacmid DNA is purified with a Fast-Filter
Plasmid Midi kit (Cat#: D6905-04. OMEGA bio-tel). Purified recombinant bacmid DNA
was transfected into SF9 insect cells (2 ml, 6 wells) in 5 to 7 days. A supernatant of the
culture was harvested and stored as passage 1 (P1) virus. The P1 virus is amplified to P4
virus at 27 °C in a 120 rpm rotational shaker. Note that the concentration of Sf9 cells has
to be kept around 1.0 × 10K )W>>/*>. After 3 days of infection of a virus, the Sf9 medium
should not be cloudy. If the medium color gets clouded, this means that the Sf9 cells were
not infected. To amplify, a passage of virus is usually increased ten times; P1 (2 ml) to P2
(20 ml), P2 (20 ml) to P3 (200 ml), and P3 (200ml) to P4 (1 L). The P4 virus of myosin 5c
(10 ml) and P4 virus of calmodulin (3 ml) were added into new Sf9 cells (1 L) and
incubated 2 to 3 days to express myosin 5c with calmodulin. Then, Sf9 cells were harvested
by centrifugation; 5,000 rpm, 5 min, at 4 °C (Rotor: JA-10, Model: J2-MI, Company:
Beckman). The pellets were rinsed twice with 1x PBS by the same centrifugation. The
resulting pellets were immediately frozen by liquid nitrogen and stored in a -80 °C freezer.
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Before the protein purification, 1.5x extraction buffer, 5x low-salt buffer and 10x high salt
buffer are prepared (please see the buffer section). The following chemicals are also
prepared: 100 mM ATP pH7.0, 1000x Leupeptin (2µg/ml working conc., 10 mM stock
conc., Roch) dithiothreitol (DTT) 0.1 mM working concentration, and 1000x PMSF (0.1
mM working concentration, 100 mM stock). Sufficient crushed ice is needed for the entire
preparation. A dounce homogenizer will be used and kept on ice. Three buffers are needed
to prepare before starting the purification. 1. Buffer A: 98 ml 1.5x Extraction buffer, 1.5
mg DTT, 100µl PMSF, 2 ml 100 mM ATP, 100 µl Leupeptin. 2. Buffer B: 100 ml 20 ml
5x low salt buffer and 80 ml cold ddH2O. 3. Buffer C: total 100 ml of 10 ml 10x high-salt
buffer, 0.5 ml 1 M MgCl2, 1 ml 100 mM ATP. 20 ml buffer A is added to the frozen cell
pellet and pipetted up and down to thaw it. The thawed solution was taken into to a dounce
homogenizer to homogenize it up-and-down 7 times and keep the homogenized solution is
kept in a graduated cylinder. After the homogenization for all cells, measure the volume.
Total volume should be 30 ml; if the volume is larger than 30 ml, calculate buffer A added,
or if the volume is lower than 30 ml, calculate ddH2O to add. The solution is then
centrifuged at 20,000 rpm for 15 min at 4 °C by a centrifuge (Rotor: JA-20, Beckmann).
The supernatant is taken into a 250 ml plastic bottle tube, while the pellet is discarded. 2~
5 ml M2-anti FLAG-resin (ANTI-FLAG® M2 Affinity Gel, Sigma, Cat# A220) is added
into supernatant solution. The bottle tube is rocked for 20 min at 4 ̊C. While this is rocking,
100 µl of the first pellet was saved for SDS-PAGE/western-blot checking. Here, unbound
myosin are washed with two different buffers, as low- and high-salt buffer. After rocking,
the resin solution is centrifuged 3,500 rpm at 4 °C by using a benchtop centrifuge (Sorvall
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Legend X1R, Thermo Scientific). The supernatant is discarded and the resin pellets are
rinsed with buffer B (30 ml) and centrifuged again. Resin will be rinsed twice by buffer C
and B. The final resin pellet is transferred into a filtered column and set in a refrigerator
at 4 °C. An elution buffer is prepared with a total volume of 20 ml containing 2 ml 10x
high-salt buffer, 2 ml 3M KCl (Final 0.8 M), and 300 µl flag peptide (Sigma-Aldrich). The
elution buffer is applied slowly onto the column and the elution from the column is
immediately collected in an Eppendorf tube, 0.5 ml each. Expecting myosin 5c solution
will be eluted at the third to tenth. Immediately, these Eppendorf tubes are analyzed by a
SDS-PAGE/western-blot. After identifying myosin 5c fraction, myosin 5c solution is
concentrated by a spin column (Amicon Ultra-15) until around 300 µl. Finally, myosin 5c
concentration is measured by using a spectrophotometer with equations from 2.1.2.2. The
molecular coefficient and molecular weight of myosin 5c-HMM and myosin 5c-HMMSNAP are 115810 M-1cm-1, 129106 Da, 138395 M-1cm-1, and 149952 Da, respectively. If
myosin is not used immediately, 10 µl of myosin 5c solution is dropped into liquid nitrogen
to make frozen balls and stored in liquid nitrogen for future use when needed.

2.1.6 Myosin 5c-HMM coated beads
Purified myosin 5c was mixed with spherical polystyrene beads and incubated for
a short time on ice to bind on the bead’s surface. The mixing ratio between myosin 5c and
beads is 1:10,000 to prevent multiple myosin 5c molecules binding on the beads to limit
the interactions of multiple motors on the actin filaments.
The typical stepping trace showed in Figure 2.2.

Most of the steps are

unidirectional with about a 36 nm step-size which coincides with the actin helical repeat
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and the typical step size of myosin 5. Sometimes a backward step may occur that may be
an actual backward step or myosin 5c detaching from actin and being pulled back to the
center of trap.

Figure 2.2 Myosin 5c on polystyrene bead stepping trace. A typical stepping trace of
myosin5c-neads. Myosin5c-beads were trapped by the laser and takes steps along an actin
filament.

2.1.7 Zymogen granule preparation
2.1.7.1 Buffer preparation
Homogenization buffer (H-buffer) is prepared from stock solutions of the
following: 1M MES (pH 6), 2M Sucrose, 0.1M MgSO4, 0.1M EGTA, 0.1M PMSF. These
are then diluted to 10mM, 300mM, 0.1mM, 1mM and 0.5mM respectively for use in the
purification of zymogen granules.

2.1.7.2 Zymogen granule purification
Zymogen granules are purified from rat pancreas as detailed by Chen.65 The
purification begins by obtaining a rat pancreas. The rats (strain CD, duration two months)
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were used under the guidelines of protocols approved by the Wayne State University
Animal Care and Use Committee. My supervisor, Prof. Takeshi Sakamoto, scarifies the rat
and dissects the pancreas. The animal protocol number of Prof. Takeshi Sakamoto is 1609-135.
The pancreas is minced into small pieces in H-buffer and then homogenized at high
speed for several strokes until all the minced pieces have more or less liquefied. The
homogenate is centrifuged (Sorvall Legend X1R, Thermo Scientific) at 250g for 10 min at
4 ̊C. Next, the supernatant is centrifuged again at 1500g for 10 min at 4 ̊C. During this
centrifugation a solution containing 5 ml of 100% Percoll®, 1 ml 2M sucrose and 60 µl 1M
MES is prepared. When the second centrifugation is finished, remove the supernatant and
suspend the pellet in a few milliliters of H-buffer. Combine this suspension with the
Percoll® solution made earlier and mix well. The combined solution should be
approximately 8 ml. This should be spun in an ultracentrifuge (Beckman Coulter Optimax
Max-Up Ultracentrifuge, MLA-55 rotor) at 30,000 rpm for 20 min at 4 ̊C. This separates
the ZGs through the Percoll® gradient. Two white bands should be produced. Take the
bottom white band from the centrifuge tube and combine with H-buffer to a total volume
of 10 ml. Lastly, this is mixed well and spun at 2000g for 15 min at 4 ̊C. Remove the
supernatant and suspend the white pellet in 500 µl ~ 1 ml of H-buffer. The purified ZGs
are now ready to be used.

2.2 Apparatus
2.2.1 TIRFM and Optical trap

38

In many optical trapping systems, the optical trap is a stand-alone system. However,
in our case we have integrated a modular system into our current microscope setup. This
is beneficial for given us the ability to simultaneously conduct trapping experiments while
utilizing TIRFM. The reason we elected this scheme is to allow us to identify fluorescently
labeled actin near the cover glass surface so that we can bring the trapped ZGs over the
actin filaments to allow them to bind (Figure 2.3).

Figure 2.3 Integrated optical trap schematic. Illustration of our combined TIRF
microscopy-optical trapping system. Beam expander (BEx), dichroic mirror (DM), mirror
(M), lens (L), objective lens (Obj.) and condenser (cond.) shown.

2.2.2 Optical trap
The optical trap setup that we use (Figure 2.3) begins with a fiber optic laser diode
that generates a 976 nm infrared beam. This laser is first incident on a pair of galvo-mirrors
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that can be controlled using a variety of software. In this way it is possible to create multiple
traps from a single laser beam by rapidly flickering the mirrors at a high frequency. After
the galvo-mirrors, the beam enters a 5x beam expander (Thorlabs, GBE05). The next
component is a pair of lenses that are used as a telescope in order to control the convergence
and divergence of the beam. This allows for the fine tuning of the depth of the trap in the
sample, as more converging the beam is entering the objective the shallower the trap will
be. Similarly increasing the divergence of the beam entering the objective with push the
trap deeper into the sample. Once the beam exits the telescope it reflects off of two post
mirrors in order to raise the beam to the appropriate level to enter into the microscope.
Before entering the microscope it reflects off of one dichroic mirror and enters the
microscope where it reflects off another dichroic mirror that directs it into the back of the
objective lens.
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Figure 2.4 Optical trap setup. Schematic of optical trap setup. Galvo mirrors (GM), beam
expander (BE), telescope formed from two lenses (L1 and L2), post mirrors (PM), dichroic
mirrors (DM), objective lens (OBJ), condenser (CON), quadrant position detector (QPD)
and cameras (CCD).

Once the laser goes through the objective lens (60x, N.A. 1.49, name of obj.,
Olympus America), using an appropriately high numerical aperture, the laser will be very
tightly focused, this is essential to creating a strong and stable trap. The trapping laser in
our case also serves as a detecting laser, as past the sample the beam is collected in a
condenser, reflected off a dichroic mirror and through a focusing lens where it is focused
onto a quadrant position detector (QPD).
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The microscope image is seen on a monitor using a CCD camera that is used to
visualize the positioning of actin filaments and particles to be trapped. There is a second
CCD that is placed behind the dichroic mirror outside of the microscope, DM1, which can
be used to visualize the shape of the IR laser spot. This is done by removing the IR filter
and imaging the reflection off of the sample on a separate monitor. In this way coarse and
fine tuning of the alignment of the optics can be done and their effects immediately seen
in the distortions and shape changes to the reflected airy disc on the secondary CCD.

2.2.2.1 Laser alignment
The most critical factor in generating a strong and stable optical trap is the proper
alignment of the trapping laser. In our particular setup, this is achieved in several steps
throughout the optical setup. Firstly, the laser is adjusted directly at the output of the laser
diode to ensure proper collimation. At all steps in the setup the use of an infrared viewing
card can be used to ensure a quality beam shape and to check that the beam is passing
through the center of all the components on its way to filling the back of the microscope
objective.
Two of the most important sections to take particular care of during the alignment
process is through the path of the objective and the path to the QPD. With the objective
lens removed, the path of the trapping laser must be straight. This is checked with a screw
on infrared detector card on the objective turret. Any adjustments are made to ensure that
the laser is in the center of the objective port and also in the center of the light source
aperture approximately a foot above the microscope stage.
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Once this is achieved the objective lens is placed in the path and some fine tuning
of the trap can be done. To check the shape of the trap created, a coverslip is placed over
the objective lens and the symmetry of the trap is visualized on the CCD to the right of
DM1 in Figure 2.1. This camera has its IR filter removed and the shape of the trapping
laser as it is reflected off the coverslip is seen on a monitor. It is important to have a
symmetrical airy disk pattern, if the laser has significant misalignments the trap may be
very asymmetrical and not able to generate a strong trapping force. This can be done in
conjunction with using an IR viewing card after the objective lens. There should be a
perfectly symmetrical airy pattern on the viewing card after the objective as well.
Once the previous steps are sufficiently achieved the laser alignment onto the QPD
can be done. The condenser is lowered to a few millimeters above the sample and the QPD
can be removed to use an IR viewing card for course aligning the laser by adjusting the
DM after the condenser. Fine adjustments of the alignment are then made by using the
adjustment knobs on the focusing lens holder. Once the laser is satisfactorily centered in
the path of the QPD care must be taken when positioning the condenser, depending on the
laser power used and the height of the condenser above the sample, the voltage on the QPD
can become damaging. Monitoring this and final alignment fine tuning are made easier
with the QPD software which shows the laser positioning on the QPD and the strength of
the laser incident on the QPD. Using the software allows for adjusting the focusing lens to
exactly center the laser on the QPD and adjusting the condenser height or laser power to
ensure the sum voltage does not overwhelm the detector.
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Figure 2.5 Software image of laser alignment on QPD. Image of trapping software. The
green bar at the right displays the sum voltage on the QPD and micro adjustments allow
for centering of the laser on the QPD. Figure from the OTKBFM-Cal Calibration and
Measurement Module for OTKB with OTKBFM User Guide, Thorlabs (2018).

2.2.2.2 Position calibration
During a single-beam trapping experiment, the position fluctuations of the trapped
particle are recorded on a QPD. As the particle is exhibiting thermal fluctuations, the laser
is collected past the sample and focused onto the QPD which records a voltage. The voltage
on the QPD is determined as shown in Figure 2.5.
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Figure 2.6 Quadrant Photodiode function. Schematic showing how the X and Y voltage
signals are calculated. Figure from the OTKBFM-Cal Calibration and Measurement
Module for OTKB with OTKBFM User Guide, Thorlabs (2018).

When recording data using the QPD of an optical trapping system, it becomes
important to convert the signal from volts to a meaningful displacement, nanometers for
example. This conversion factor, usually called the QPD sensitivity, β, can be determined
in a few ways.
One of the simplest methods for calibrating the QPD is the stuck bead method.
Here a bead is immobilized on a cover slip and the stage is oscillated through the trapping
area. As the bead traverses the trapping area the rising and falling voltage detected by the
QPD generates an S-curve which is linear for small displacements from the trap center. It

45

is from this linear fitting that a relationship between QPD voltages and displacement can
be determined.

Figure 2.7 Position calibration S-curve. To determine the QPD sensitivity factor, a
voltage signal is acquired while moving a stuck bead across the focus of the optical trap.
When a bead is trapped in the beam of optical tweezers, the Brownian motion is recorded
via a QPD. While the bead is fluctuating inside the trap it is scattering the laser beam on
the QPD and generates a voltage signal. In order to convert this voltage signal into a
displacement, some conversion factor is needed. To determine how this voltage correlates
to displacement one technique that can be used is the stuck bead method. By moving a
stuck bead over the center of the optical trap a known distance the voltage signal traces out
an S-curve that can be fit in the linear region. For this small range of displacements, the
QPD voltage response is linear, and a simple fit can determine our sensitivity factor.
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There are several problems with this method, however. In using this method, the
stuck bead triggering the QPD is not precisely in the axial position that the trapped particle
would be in an experiment. During an experiment when the laser creating the trap is
focused inside of a flow cell there will always be a net force from the radiation pressure of
the laser in the direction of laser propagation. Furthermore, in order to reduce the effects
of the interactions between the cover slip wall and the trapped particle it is necessary to
focus the trap far enough away from the wall to reduce these effects during an experiment.
Because of these interactions the possibility that the forces between the stuck particle and
the surface may also influence the sensitivity of the QPD measurements and misrepresent
the actual sensitivity in experimental condition is quite high.
A much better approach to determining the sensitivity of the QPD relies only on
the power spectrum data of a trapped bead. This method, termed the plateau method,
involves taking the power spectrum data, < 4 and plotting 4 < 4 versus f. This graph
will have a plateau value for frequencies much larger than the corner frequency and from
this we can determine the sensitivity factor.
The starting point for this derivation, and for most all things involving optical
trapping, is the Langevin equation with a harmonic potential. The Langevin equation,
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with the inertial termed dropped at low Reynold’s number, is transformed and the force as
a function of frequency is solved:
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The one-sided power spectrum is then:
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Figure 2.8 Graph of the one-sided Lorentzian power spectrum.
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Figure 2.9 Graph of the plateau method.

By graphing the power spectrum, the “stiffness” of the optical trap can be
determined from the relation between the spring constant and the corner frequency. Taking
the power spectrum data and converting it to the plateau graph is the method for
determining the sensitivity factor as mentioned previously. The power spectrum can be
rewritten as:
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Notice that the units are volts2/Hz. However, we would like the units to be dist2/Hz.
We can rewrite the power spectrum with some factor that converts these units:

< 4 [%*] =

< 4

Where α2 has the units votls2/dist2. When the power spectrum is multiplied by f 2
the function f 2S(f) reaches a plateau, Pv, for f>>f0.

4 < 4 =

<b 4 = k l

By determining the plateau value, this conversion factor is solved for then the
sensitivity factor, β = 1/α, converts the QPD signal into dist/volt.

2.2.2.3 Force calibration
One method for determining the trap strength is to utilize the equipartition theorem.
In our case the thermal fluctuations of a trapped particle inside a harmonic potential obeys
the following:

1
1
m1 2 = n < + >
2
2

where m1 is the Boltzmann constant, T the absolute temperature, n the trap strength

(“stiffness”), and < + > is the positional variance from the trapping equilibrium position.
Some advantages of this method are its simplicity and the fact that no information
about the trapped particle needs to be known. The size and shape of the particle nor the
viscous drag or viscosity of the medium needs to be known, simply just apply the
equipartition theorem. Additionally, this method can be used in combination with the QPD
data in an attempt to estimate the sensitivity factor mentioned in the previous section. By
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defining the sensitivity factor as the ratio of the stiffness of the trap determined by the QPD
and the CCD:

npqD [rts ]
μ*
o=
= o[ ts ]
nuuD [rtμ*]

Here N/V and N/µm are the units of the spring constant as determined using the
QPD and CCD respectively. This method for determining the QPD sensitivity is inferior
to that mentioned previously due to the use of the equipartition method and its drawbacks
in determining the spring constant from the CCD.
The drawback of using this method is large error and inaccuracy in determining the
trap strength. Because variance is a squared quantity, any noise or position shift in the trap
will greatly amplify the variance and thus underestimate the stiffness. Another factor to
consider when using this method is the detection of the variance. One way is to use very
accurate tracking software on the monitor that is visualizing the trap in order to try and
mitigate the compounding error in the variance calculation. Alternatively, using the power
spectrum is possible as the variance is the integral of the position power spectrum. However
this necessitates additional steps to ensure the detector is properly calibrated when
measuring the power spectrum.66
An extension of the equipartition theorem is to determine the complete probability
distribution of the displacement. This probability distribution will be a Boltzmann
distribution given by:

− +
−n+
k + ∝ exp z
{ = exp z
{
/1 2
2/1 2
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In a harmonic potential this distribution will be a simply Gaussian determined by
the trap stiffness, κ. If for some reason the potential was anharmonic, a position histogram
could be used to determine the shape of the potential. This extension of the equipartition
theorem is not very useful however as it does not include any new information. If
determining the shape of some anharmonic potential is the goal this is also limited as the
positions farther from equilibrium which contain the most important information will also
have the fewest counts and therefore the highest uncertainty.66
Another method for determining the force of the trap more directly is the drag force
method. The simplest version of this method would be to move the particle through the
trap at increasing speeds until some maximum speed where the particles falls out of the
trap. Using Stoke’s law and the force of friction, the force exerted by the trap is given by:

= 65}B~

Care must be taken to perform this method at a constant distance from the coverslip
and far enough away that surface interactions are not an issue, otherwise Faxen’s law
corrections to the drag coefficient must be considered.
More sophisticated versions of this method involve measuring the trapped particles
displacement from viscous forces generated by moving or oscillating the sample in various
ways. Oscillating the stage sinusoidally it is possible to determine the trap strength from
the amplitude and phase of the bead motion. Other variations include using a triangular
driving force or the step response method, where the bead is quickly displaced a known
amount and using the time constant of the bead returning to equilibrium in an exponentially
damped manner the strength of the trap can also be determined.66
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The most accurate and simplest method for determining the trap strength involves
fitting the power spectrum with a one-sided Lorentzian. With this approach, one simply
needs to trap a particle and record the thermal fluctuations. The position fluctuations with
time are transformed to the power spectrum distribution of frequencies. This power spectral
density (PSD) method is described above in section 2.2.2.2 as a precursor to the plateau
method of determining the QPD sensitivity factor. Looking at the power spectrum equation
and comparing it to the Lorentzian, it is clear that the trap strength follows the simple
relation:

n = 25-4(

This method avoids all of the compounding inaccuracies of the equipartition
method with the only drawback being that some information about the trapped particle and
the medium be known. Namely, the radius of the trapped particle and the viscosity of the
medium you are trapping in.

2.3 Experimental protocol
2.3.1 Chamber preparation for optical trap assay
Preparing a flow cell for optical trapping varies slightly depending on the
experiment. For a simple trap calibration a flow cell is created by using double-sided tape
on a microscope slide to adhere a coverslip (Fisher, Cat # 1248C, Size 25x25x1 mm). Once
the coverslip is secured to the slide, a chamber of approximately 30 µl is created. For trap
testing with beads for example, the beads are diluted in water enough so that there are not
too many in the sample that makes it difficult to trap a single bead. Enough of this dilution
is injected into the flow cell with a pipette to fill the chamber.
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For stepping experiments the flow cell is built the same way, however several steps
are taken to treat the coverslip appropriately to bind actin to the surface. First the coverslip
is treated to create a hydrophobic layer. This is done by preparing a solution of 2%
methacryloxypropyltrimethoxysilane (Silar laboratories, product # 1210) in acetone
creating a silane solution. The coverslips are dipped in the silane solution and incubated
for approximately one to two minutes. They are then taken out and again incubated for a
few minutes in pure acetone. After the acetone incubation the coverslips are left in a rack
to dry and will then be ready to be used.
The chamber preparation for stepping experiments begins with these hydrophobic
coverslips. A flow cell is created as mentioned above with double sided tape, securing the
treated coverslip to a microscope slide. The objective is to tether actin filaments to the
coverslip so that ZGs can bind to actin during optical trapping. In order to achieve this, a
layer of biotin-BSA is added and then streptavidin to bind the biotin. Because of the
structure and strong binding affinity between biotin and streptavidin, a layer of biotinylated
actin can then bind and in this way the actin is secured to the cover slip, but not directly on
the coverslip which would influence the ability of myosin to move along the actin filaments.
A series of solutions will be injected into the flow cell with a pipette, beginning
with approximately 30 µl of biotin-BSA. This is allowed to incubate for two minutes.
Approximately 50 µl of streptavidin is added and also allowed to incubate for two minutes.
Next, 50 µl of BSA is added and after incubation for two minutes the flow cell is washed
with 200 µl of MB. This will help to wash away any unbound streptavidin. Now
approximately 50 µl of 5 µM biotinylated RHPH actin is added and allowed to incubate
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for five minutes. The chamber is washed again with 200 µl of MB to wash out any unbound
actin. The chamber can now be checked on the TIRF microscope to inspect the quality of
actin binding achieved. The basic flow cell is finished and is now ready to be used and
injected with ZGs and the appropriate chemicals depending on the experiment being
carried out.
In a typical ZG stepping experiment, the flow cell is injected with a final mixture
of ZGs and other chemicals. Included in this mixture is 4 µl of 1mg/ml BSA, 4 µl of 1M
DTT, 4 µl of 125 mg/ml glucose, 2 µl of GO all in 1 x MB. Finally in this solution is the
desired concentration of ZGs, KCl, and ATP. The ZGs are diluted substantially from a
purified sample, enough as to reduce the overcrowding of the chamber and avoid trapping
multiple ZGs during an experiment. The KCl and ATP concentrations are determined based
on experiments and are often varied form very low to quite high.

2.3.2 Data collection
During the typical stepping experiment, a ZG is trapped over a coverslip of tethered
actin filaments. When ATP is added to the chamber as described in the previous section,
the myosin on the surface of the ZGs are able to step along the actin filaments. The software
used to track the motion of the trapped particle records position data at 131 kHz. This
correlates to a data point approximately every 7.6 µs. The software transforms this position
data into the power spectral density for fitting and determining the trap strength as
described earlier in section 2.2.2.3. The raw data for the position and power spectrum can
be saved as excel files. Using the method described in section 2.2.2.2 to convert the raw
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voltage data into displacement data, the position fluctuations can be graphed to investigate
the stepping behavior.

3. Results
3.1 Western-blot analysis of myosins
Mass spectrometry analysis discovered four kinds of myosin: myosin 1c, myosin
5c, myosin 6, and myosin 7b.65 To confirm whether our purified ZGs’ surfaces have these
myosins, enhanced chemiluminescence (ECL) western-blot (WB) analysis was performed.
As a control sample, we used rat leg muscle. In Figure 3.1 A, Coomassie Blue (R-250)
staining of SDS-PAGE gel (12% Bio-Rad Mini Protein TGX Gel) shows whole protein
bands. Lane 1 and 2 are pancreas and leg muscle tissue, respectively. Lane “L” is a protein
ladder (Cat#: 1610374, Bio-Rad). ECL WB analysis shows Myosin 5c bands (210 kDa)
in lane 1, while lane 2 has no myosin 5c bands. Myosin 1c and myosin 6 bands were not
shown in the ECL WB.
As a control for the ECL WB, Rab27B and VAMP2 proteins were examined. Both
Rab27b (24 kDa) and VAMP2 (13~18 kDa) are shown more in leg muscle and pancreas,
respectively. This means that ECL WB method works well for those proteins.
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Figure 3.1 ECL western-blot analysis. The letter and numbers on the top of gel represent
the following: L: protein ladder, 1: Pancreas, 2: Leg muscle. (A) Coomassie Blue staining
for entire sample. (B~E) MYO5c as Myosin 5c, MYO1c as myosin 1c, MYO6 as myosin
6, and MYO7b as myosin 7b, respectively. (F and G) Control proteins, Rab27b and
VAMP2 on the surface of ZGs. Red arrow heads represent expected protein bands.

3.2 Optical trap tuning
3.2.1 Determining trap strength
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In order to determine the trapping the strength for any particular laser power the
PSD method is used as described in sections 2.2.2.2 and 2.2.2.3. The software used to
collect the fluctuation data and fit the power spectrum data is from the Thorlabs calibration
and measurement module (Thorlabs, OTKBFM-CAL).
When calibrating the system for a given particle, whether a polystyrene bead or
zymogen granule, a flow cell is created with a microscope slide and coverslip as descried
in section 2.3.1. The sample is injected into the flow cell and put over the objective and the
particle is then trapped. Using the software, some information about the particle and
medium is needed to perform the PSD fitting. The size, medium viscosity and temperature
is input into the software then the calibration can be run.
The length of the calibration can be set as desired and averaging can be done to
remove noise from the PSD. Figure 3.2 shows an example of the PSD fitting procedure.
The calibration length refers to the time over which data is collected. Averages, in the
example in fFgure 3.2 this is set to 10, means that data is collected for one second and this
is done 10 times and averaged to generate the PSD graphs shown. The fitting endpoints
can be adjusted to find the best fit for the graphs and the software automatically updates
the corner frequency and spring constant calculated.
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Figure 3.2 Power spectral density fitting using software. Screenshot of determining the
trapping strength using the PSD method. The fitting software allows for the selection of
the endpoints for the best fit and displays corner frequency obtained from the fitting and
the trap stiffness. Figure from the OTKBFM-Cal Calibration and Measurement Module for
OTKB with OTKBFM User Guide, Thorlabs (2018).

3.2.2 Trap strength vs. particle trapped
There are several factors that influence the strength created by an optical trap. Some
more obvious ones include the laser power used. This is a result of the power the laser is
capable of generating and also the optical setup and alignment. The alignment is crucial as
this can dramatically increase the power at the trapping site for even relatively low laser
powers.

59

Using a high NA objective lens also increases trap strength. High NA objectives
are often used in optical trapping experiments as they allow for the gathering of more of
the trapping laser and drastically increase the power focused at the trapping spot. Many
available modular optical trapping kits will use objective lenses with an NA of 1.2 or higher.
Another component of the strength of an optical trap is the trapped particle itself.
When trapping silica or polystyrene beads, the large difference in refractive index between
the water and the particle itself increases the trapping strength tremendously. This index of
refraction difference is one of the most impactful factors in the trapping force felt by the
particle that is trapped. In addition to the refractive index, the size of the particle that is
trapped influences the force it feels. Figure 3.2 illustrates the effect of size on trapping
strength. The error bars in laser power represent the ~3% error in the sensor used while
those of the measured stiffness of the trap are the standard deviation in several
measurements at each power. The power for these measurements were measured after the
objective.
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Figure 3.3 Trap strength for different particles. Graph showing the relationship between
the particles trapped and trap strength and the trapping laser power and trap strength. 1.1
µm PS bead , 3.37 µm PS bead , ZG , 7.24 µm PS bead .

The forces felt for varying particle sizes can be separated into three regimes: The
Rayleigh regime (d << λ), the Mie or ray-optics regime (d >> λ), and the Generalized
Lorenz-Mie Theory (GLMT) (d ~ λ). In the Rayleigh regime, where the particle is treated
as an electric dipole, the force tends to increase as r3 and in the Mie regime the strength
becomes independent of radius for particles with r > 10λ.67
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An interesting thing to notice in Figure 3.3 is the large forces produced when
trapping the one micron bead. This is consistent with observations that the maximum force
is produced when the particle radius is equal to the beam waist.68

3.3 Determining the step-size with different time filtering
To determine the step-size of a trapped object in our system, position data was
averaged with different time windows of 1, 5, 10, and 30 ms (Figure 3.4). 1 or 5 ms time
windows are the best at finding the stepping of the beads. Lager than 5 ms starts to lose
some stepping information through over filtering the data while less than 1 ms contains
noisier data that is similar to the raw data. Depending on the raw data a 1-10 ms time
window is chosen as this allows for better visualization of the stepping behavior without
over averaging and missing any steps (see Figure 3.4 D for an example of over averaging).
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Figure 3.4 Stepping trace of Myosin5c-beads with different time averaging. A typical
stepping trace by optical trap shows a few steps. A, B, C, and D are different time averaging
with 1, 5, 10, and 30 ms, respectively. Light gray is the raw position data. The black solid
line is the averaging time. Note that the acquisition time is 7 microseconds. Blue arrows
represent a missing step.

3.4 Trapping ZGs
When trapping ZGs in solution and recording the thermal fluctuations, one would
expect the position graph to be that of pure white noise. When conducting the same trapping
experiment in the presence of an actin bound coverslip, the variance in the noise is
dramatically decreased. We would expect this to occur in the case of ZGs binding strongly
to the actin filaments. In Figure 3.5 A, the thermal motions in solution and in actin binding
in the absence of ATP were detected. The black and red lines in Figure 3.5 A are raw data
and 5 ms time window averaging data. The variances of these data are calculated in solution,
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e.g. without actin, and with actin, respectively. The data were fitted by a Gaussian
distribution (red line). The S.D. without and with actin are 34.3 ± 7.5 and 13.1 ± 5.2,
respectively (Figure 3.5 B). If several of the molecular motor myosins on the ZG surface
bind to actin in the absence of ATP, this binding would significantly reduce the thermal
motion of the ZG. The distribution with actin obviously reduces the variance. We conclude
that myosins on the ZG’s surface reduce thermal fluctuations via strongly binding to actin
filaments.

Figure 3.5 Binding of ZGs to actin. A. Position fluctuations of a ZG in solution (bottom)
and in solution with actin coated coverslip (top). B. Histogram of position fluctuations in
solution. C. Histogram of position fluctuations in the presence of actin.
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Another method for investigating the binding of ZGs to actin is by varying the KCl
concentration. The actomyosin interaction is electrostatic, therefore drastically altering the
ionic strength of the solution will prevent the stable binding of myosin to the actin filaments.

Figure 3.6 ZG binding to actin in low and high KCl concentrations. A trace of ZGs
trapped over actin in 50 mM KCl (teal) and in 600 mM KCl (purple) in the presence of 1
mM ATP. Below and side inset showing the standard deviation of the fluctuations.

In Figure 3.6, we show the large increase in positional variance when trapping ZGs
in high KCl concentration conditions in the presence of ATP. These conditions are vastly
detrimental to myosins ability to bind to actin, therefore the distribution of the S.D. in the
presence of 600 mM KCl increase similar to that seen when trapping in solution without
actin.
The variance analysis with different solution condition show that myosins on the
surface of ZGs bind to the actin filament where immobilized on the cover glass surface.
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The fluctuation patterns are random and there is no unidirectional movement and/or
stepping.

3.5 Step-size of ZGs
In order to determine the step sizes of ZGs moving along actin filaments, several
quality stepping traces were analyzed, each with many stepping events.

Figure 3.7 Example portion of a stepping trace of a ZG with 1 mm ATP. Section from
a ZG stepping trace (left). Inset shows 200 ms portion of rapid movement (right) that is
much faster than solution kinetics for an individual myosin.

Figure 3.7 shows a typical stepping trace with raw data (black dots) and average
position of ZGs (red line). During many of these stepping events there are short bursts of
rapid movement (Figure 3.7 and expand in inset), much faster than the kinetics of a single
myosin would allow (see inset of Figure 3.7). One possible explanation for this movement
is the cooperative work of multiple motors translating the ZG as it either slides or rolls
along the actin filaments.
When combining dozens of stepping traces and analyzing hundreds of stepping
events, we can construct a histogram in order to determine what the most frequent step
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sizes are during the ZG movement. It is important to note that myosin movement is
directional. Actin filaments polymerize in one direction with one end being denoted the
plus end and the other the minus end. Typically, most myosin move along actin toward the
plus end. However, myosin 6 is a backwards moving myosin, meaning that it moves along
the actin filaments towards the minus end. This is something to keep in mind when
analyzing ZG steps and their direction.

Figure 3.8 Histogram of ZG stepping events. Histogram of ZG stepping events showing
5 distinct peaks corresponding to the most frequent step sizes observed. From left to right
the peaks are -33.4 nm, -19.2 nm, 14.7 nm, 37.5 nm, and 78.3 nm.
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The step direction was defined as the most frequent direction being positive and the
other direction being negative. From the steps sizes seen in Figure 3.8, there are a few
interesting things to notice. First, the most frequent step size of 37.5 nm is closely
correlated to the typical myosin step size of approximately 36 nm that coincides with the
actin helical repeat. Second, there are also varying sized intermediate steps and a significant
amount of backward steps.
We suspect from the complicated tug-of-war interaction between the many species
of myosin on the ZG surface is responsible for the numerous intermediate step sizes. The
presence of myosin 6 on the ZG membrane, being a backwards directed motor, would be a
possible explanation for the significant amount of back-stepping observed. When
comparing the number of forward to backward steps, we see a backward step percentage
of about 35%.

3.6 Dwell-time
The dwell time is a key factor to predict whether a molecular motor is processive
or not. We measured the dwell time at different ATP concentrations. To be a processive
motor, the ADP dissociation step should be a rate limiting step, because of the strong
binding state between the myosin head and actin. Recently, transient solution kinetics
studies from two labs (Ikebe & Sellers) showed that single-headed myosin 5c-S1 (Myo5cS1) has a low duty ratio (~20%), spending most of its ATPase cycle (80%) in a weak actinbinding state69, 70, increasing the probability that both heads detach at the same time.
Consistent with its biochemical properties, single molecule two-headed myosin 5c studies
confirmed that myosin 5c is a non-processive motor, i.e., a single myosin 5c molecule does
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not continuously move along actin filaments.69,
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However, we recently performed a

kinetic study on two-headed Myo5c-HMM fragments that are similar to myosin 5a, e.g.
the ADP dissociation of Myo5c-HMM is biphasic. This biphasic nature of ADP
dissociation can be expected when there is an internal strain between the leading and
trailing head.71 In fact, our results showed that the duty ratio (40%) of two-headed Myo5cHMM is higher than that (~20%) of Myo5c-S1, but these properties do not produce
processive movement by a single molecule yet. Two two-headed Myo5c-HMM were
attached to a DNA scaffold and was observed to be processive by single molecule TIRFM
(see reference Sakamoto). Thus, we expect that the non-processive myosin 5c may work
together with other motors as an ensemble. Myosin 5a binds neuronal vesicles (φ: 40nm),
while myosin 5c binds ZGs (φ: 1000nm), the surface curvature of ZGs being much flatter
than that of the neuronal vesicle. For this reason, it is more possibility for myosin 5c to
work together with other motors.

3.6.1 Dwell time analysis with different ATP and KCl concentration
The dwell time during stepping of ZGs on actin was measured at different ATP
concentrations as well as at high ionic strength, e.g. 600 mM KCl. Note that the binding
between the myosin head and actin is an electrostatic interaction. The ionic strength in a
physiological condition is around 50 ~ 150 mM. Higher than 300 mM KCl concentration
will cause detachment of myosin heads from actin. In order to identify whether there is
binding of ZGs on actin filaments, we have analyzed thedwell time with different ATP and
KCl concentrations.
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In this dwell time analysis, I have used a simple kinetic model as the chemomechanical cycle with two irreversible steps with different rates, k1 and k2 72, 73. ADP
dissociation rate is k2 while k1 includes all other steps.

The Dwell time distribution can be predicted with this simple model:

k , /M , /

=

/M /
/M − /

exp −/

− exp −/M

The time window was set to 5 ms for finding dwell time and steps in this study. In
this case, less than 5 ms dwell time cannot be identified as there will be missing events due
to the limited time window. I therefore excluded the faster events from this analysis. The
dwell time for four different ATP conditions were analyzed in Figure 3.9. Overall dwell
time was plotted as a function of ATP concentration (Figure 3.10 A) and depends on the
ATP concentration. The predicted equation could not fit 1 mM ATP and 1mM ATP + 600
mM KCl. This is because the fast rates of both are faster than 200 s-1 (< 5ms). The fast rate
(~50 >200 s-1) depends on ATP concentration, while the slow rate (~15 s-1) is only partially
dependent on ATP concentration (Figure 3.9 B.) Note that a star and blue circle in Figure
10 B are predicted faster (>200 s-1) rate and in the presence of 600 mM KCl, respectively.
The fast rate can be k1 depending on ATP concentration, while the slow rate can be k2
depending on the ADP dissociation rate.
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Figure 3.9 Dwell time for four different conditions. A. 0.1 micromolar ATP, B. 1
micromolar ATP, C. 1 millimolar ATP, D. 1 millimolar ATP and 600 millimolar KCl
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Figure 3.10 Average dwell time. A, average dwell time for different ATP concentrations.
B, rate dependence on ATP concentration.

72

Figure 3.11 ADP dissociation rate. ADP dissociation rate dependence on ATP
concentration.

Comparing previous research such as Cleman et al, 2005 and Altman D, 2004, our
data of the slow rate, k2, does not agree with their results, because of the dependence on
ATP concentrations for ADP dissociation. Clemen et al., suggested that an external force
does not affect the stepping rate and does not affect the ADP dissociation rate, because of
the internal strain. Cleman et al., also suggested that a single-headed myosin 5a is affected
by an external force. In the case of myosin 5c, the trailing head may not bind for a long
time due to the low duty ratio and may dissociate from actin as a function of ATP
concentration. The internal strain of Myo5c may be weak, thus, the slow rate of ADP
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dissociation may depend on ATP concentrations. Besides, our previous results showed that
the duty ratio of two-headed myosin 5c can be optimized from single-headed Myo5c-S1 to
two-headed Myo5c-HMM and was relatively lower than myosin 5a, but has a biphasic rate,
e.g. internal strain may exist on two-headed Myo5c-HMM without an external force. As
myosin 5c is a low duty ratio motor, the trailing head of Myo5c-HMM will easily dissociate
from actin, and the leading head may stay attached as single-headed Myo5c. In this case,
the external force from the optical trap or the thermal fluctuation will affect the ADP
dissociation. Thus, the ADP dissociation rate may be affected ATP concentration. The
dwell time of four different conditions were fit with the exponential equation above.

3.6.2 Low power optical trap
The Laser power was decreased from 53 mW to 15 mW, and trapping stiffness was
decreased from 0.05 pN/nm to 0.015 pN/nm. In these weaker traps, the variance of the
ZG’s position increased as expected. The ZGs also moved more frequently, while the dwell
time increased (Figure 3.11).
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Figure 3.12 Example stepping traces using low power trap. Example stepping graphs
using a low power trap. Positional fluctuations and deviation shown.
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Two stepping traces are shown in Figure 3.11. The variance of both are slightly
increased 20 ~ 30 nm from that (~10 nm) of higher trap stiffness (0.05 pN/nm). The
stepping traces show that ZGs keep stepping around 3 to 4 steps and get pulled back to the
center of the trap which is similar behavior to the higher trap stiffness (0.05 pN/nm) case.
However, when the dwell times are fit with the dwell time equation above with two rates,
k1 and k2, the slow rate k2 decreased (see Figure 3.13) while the fast rate, k1, (~60 s-1) was
the same as 1 mM ATP with the high trapping stiffness.

Figure 3.13 Low power dwell time. ADP association rate, k2, decreases when trapping at
low power.
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The results suggest that the decreasing trapping stiffness will decrease the external
force that prevents the dissociation between the myosin head and actin. The detached and
swinging forward trailing head can have more time to find a new binding site on the actin
filament.

3.7 Myosin inhibitors
There are several known small molecule inhibitors to a number of myosin
species. One highly characterized myosin 2 inhibitor, blebbistatin, acts by binding to the
motor domain and stabilizing the closed ADP/Pi bound intermediate state.74 Another
myosin 2 inhibitor, N-benzyl-p-toluene sulphonamide (BTS), works by inhibiting the rate
of actin-activated ATPase activity and is unique in its selective effect on fast-twitch skeletal
myosin 2.75 2, 3-Butanedione monoxime (BDM) is another small molecule that has been
shown to reversibly inhibit contraction of skeletal muscle and inhibit the ATPase activity
of skeletal myosin 2.76 BDM also inhibits Pi release like many other myosin 2 inhibitors
but has a rather low affinity for myosin compared to other inhibitors requiring
concentrations near 10-mM. There are also studies suggesting the specificity of BDM is
no just relegated to myosin 2 but may also inhibit myosin 5 and myosin 6. However,
reports with contradictory data have also been published and there is no consensus as to
the specificity of BDM.76
One identified myosin 1 inhibitor is pentachloropseudilin (PCIP). Studies have
shown that PCIP binds to the motor domain of myosin near the residues where there is
binding site for blebbistatin and reduces ATPase activity.77 The specificity of PCIP seems

77

to be altered at high concentrations (>90 uM) however where it may also inhibit nonmuscle myosin 2 and myosin 5b.
The antibiotic pentabromopseudilin (PBP) belongs to the same pseudilin family as
the previous mentioned myosin I inhibitor and reversibly inhibits the ATPase of myosin
5a. PBP binds to the same motor domain pocket as PCIP and more selectively inhibits
class 5 myosins due to their increased hydrophobicity of this binding site.78 This molecule
also exhibits an effect on a wider range of myosins at higher concentrations reducing its
specificity.
An additional inhibitor, 2, 4, 6-triiodophenol (TIP), is a myosin 6 inhibitor that may
also bind to the sites used by PCIP/PBP or blebbistatin and similarly reduces ATPase
activity.79

3.7.1 TIP
Given that myosin 6 on the surface of ZGs is a backward walking myosin, we
conduct stepping experiments to examine the effects of ZG stepping patterns in the
presence of the myosin 6 inhibitor TIP.
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Figure 3.14 Stepping trace in the presence of TIP. Example stepping graph using the
myosin 6 inhibitor TIP. Position fluctuations and standard deviation shown.
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Figure 3.15 Histogram of ZG stepping events in the presence of TIP. Histogram of ZG
stepping events showing 4 distinct peaks corresponding to the most frequent step sizes
observed. From left to right the peaks are -32.1 nm, 19.5 nm, 36.2 nm, and 72 nm.

Similar to Figure 3.8, we observe stepping that correlates with the 36 nm actin
helical repeat of ~36 nm as well as several intermediate steps. However, when calculating
the back stepping percentage in the presence of TIP, which is a myosin 6 inhibitor that
reduces its ATPase activity by ~60%, we see a reduction in the back steps to approximately
16%.
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3.8 Conclusion
We have demonstrated the ability to stably trap purified ZGs using a single beam
optical trap. The use of optical trapping techniques has been used to examine the
complicated behavior of ZG trafficking and the experiments we have performed has shown
the complicated movement involved. Considering the various myosin species on the ZG
membrane surface, we believe that the multiple motors working together allow for its
transport, as even single molecule non-processive motors are known to be processive when
working together. Further, we believe that myosin 6 is responsible for much of the ZG back
stepping behavior and perhaps this myosin and possibly others have a variety of other
functions, perhaps tethering and anchoring, in addition to their trafficking capabilities.
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Zymogen granules are enzymatic vesicles in the pancreas. The surface of these
zymogen granules (ZGs) has several different kinds of myosin molecules, such as myosin
1c, 6, 5c, and 7b. These molecular motors may contribute to ZG transportation in cells. To
understand the molecular motors involved in the vesicle trafficking, we observed the in
vitro motility of purified ZGs from rat pancreas and examined the stepping behavior and
force that is generated using a single beam optical trap. To be involved in trafficking,
molecular motors have certain characteristics, a high duty ratio and the ability to move
continuously along actin tracks. The high duty ratio means that during most of the ATPase
cycle the motor is in a bound state with actin. Interestingly, Myosin 1c and 5c are low duty
ratio motors, meaning that the molecule itself cannot move continuously along the actin
filament. Recently our laboratory demonstrated that two myosin 5c molecules, when
tethered with DNA origami, move continuously and suggested that more than two
molecules of myosin 5c may be able to transport the ZGs. Besides, the surface curvature
of ZGs (diameter: 1 µm) is much flatter than that of a neuronal vesicle (diameter: 40 nm)
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that is transported by a high duty ratio motor, myosin 5a. In this case, although myosin 1c
and 5c are low duty ratio motors, these motors may be able to transport the ZGs. We found
that the complicated stepping of ZGs allow for movement using an ensemble of motors,
even non-processive motors, that when acting together on the ZG surface display
movement and kinetics much different than single molecule studies. Additionally, we
attempt to explore the impact of myosin 6, a backwards stepping motor, on the movement
in this ensemble of motors.
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